Evidence map›Paper›PMID 24075898›Full record

ArticleVirus research2013

High molecular weight complex analysis of Epstein-Barr virus Latent Membrane Protein 1 (LMP-1): structural insights into LMP-1's homo-oligomerization and lipid raft association.

Christopher M Wrobel, Timothy R Geiger, Rebecca N Nix, Aaron M Robitaille, Sandra Weigand, Alfredo Cervantes, Miguel Gonzalez, Jennifer M Martin

Abstract read
In one paragraph

Article in Virus research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

Christopher M WrobelDepartment of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309, United States.
Timothy R Geiger
Rebecca N Nix
Aaron M Robitaille
Sandra Weigand
Alfredo Cervantes
Miguel Gonzalez
Jennifer M Martin
University of Colorado Boulder · USAllergan (United States) · USAsklepios Kliniken Bad Abbach · DEBaxter (United States) · USMyriad Genetics · USUniversity of Colorado Denver · USUniversity of Washington · US

Funding

MOLECULAR BIOLOGYT32GM007135 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI KRAUTER, KENNETH S · 1985 to 2012
$5.7M
Activation of the LMP-1 Protein of Epstein-Barr VirusR01CA095043 · NCI · UNIVERSITY OF COLORADO AT BOULDER · PI MARTIN, JENNIFER M · 2004 to 2008
$1.3M
NCI NIH HHS CA095043NCI NIH HHS CA13873NCI NIH HHS R01 CA095043NIGMS NIH HHS 5T32 GM-07135NIGMS NIH HHS T32 GM007135
6 · The paper itself

Abstract

LMP-1 is a constitutively active Tumor Necrosis Factor Receptor analog encoded by Epstein-Barr virus. LMP-1 activation correlates with oligomerization and raft localization, but direct evidence of LMP-1 oligomers is limited. We report that LMP-1 forms multiple high molecular weight native LMP-1 complexes when analyzed by BN-PAGE, the largest of which are enriched in detergent resistant membranes. The largest of these high molecular weight complexes are not formed by purified LMP-1 or by loss of function LMP-1 mutants. Consistent with these results we find a dimeric form of LMP-1 that can be stabilized by disulfide crosslinking. We identify cysteine 238 in the C-terminus of LMP-1 as the crosslinked cysteine. Disulfide crosslinking occurs post-lysis but the dimer can be crosslinked in intact cells with membrane permeable crosslinkers. LMP-1/C238A retains wild type LMP-1 NF-κB activity. LMP-1's TRAF binding, raft association and oligomerization are associated with the dimeric form of LMP-1. Our results suggest the possibility that the observed dimeric species results from inter-oligomeric crosslinking of LMP-1 molecules in adjacent core LMP-1 oligomers.

Indexed as

Host-Pathogen InteractionsProtein MultimerizationElectrophoresis, Polyacrylamide GelHerpesvirus 4, HumanHumansMembrane MicrodomainsMolecular WeightViral Matrix ProteinsEBV-associated membrane antigen, Epstein-Barr virusViral Matrix Proteinsbismaleimidohexaneblue native polyacrylamide gel electrophoresisBMHBN-PAGEComplex formationEBVEGSEpstein–Barr virusethylene glycol bis[succinimidylsuccinateIFNαinterferon alphaLatent Membrane Protein-1Lipid raftLMP-1NEMN-ethylmaleimideOligomerizationTMEATRAFtris-[2-maleimidoethyl]amineTumor Necrosis Receptor Associated Factor

Identifiers

PMID24075898
PMCPMC3925771
OpenAlexW2010516418

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.